Kyongkyu Lee
Overview
Explore the profile of Kyongkyu Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahn J, Kim M, Lee K, Oh K, Lim H, Kil H, et al.
EJNMMI Res
. 2024 Jul;
14(1):59.
PMID: 38958796
Background: N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane (FP-CIT), the representative cocaine derivative used in dopamine transporter imaging, is a promising biomarker, as it reflects the severity of Parkinson's disease (PD). I- and F-labeled FP-CIT...
2.
Lee I, Kim M, Lee K, Oh K, Lim H, Ahn J, et al.
Diagnostics (Basel)
. 2023 Aug;
13(16).
PMID: 37627908
Background: This study compared the effects of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) as Cu-chelating agents in newly developed prostate-specific membrane antigen (PSMA) target compounds, Cu-cudotadipep and Cu-cunotadipep, on...
3.
Kim M, Lee K, Oh K, Kim C, Kil H, Lee Y, et al.
Biochem Biophys Res Commun
. 2023 Feb;
651:107-113.
PMID: 36801611
We have compared the similarity of the in vivo distribution of the prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agents [F]DCFPyL, [Ga]galdotadipep, and [Ga]PSMA-11. This study is designed...
4.
Lee B, Kim M, Chu S, Jung W, Jeong H, Lee K, et al.
Mol Cancer Ther
. 2021 Nov;
20(12):2410-2419.
PMID: 34725194
We developed a novel therapeutic radioligand, [Lu], with an albumin binding motif and evaluated it in a prostate-specific membrane antigen (PSMA)-expressing tumor xenograft mouse model. Fourteen PSMA target candidates were...
5.
Lee B, Chu S, Jung W, Jeong H, Lee K, Kim M, et al.
Prostate
. 2020 Sep;
80(16):1383-1393.
PMID: 32960990
Background: Prostate-specific membrane antigen (PSMA) is increasingly recognized as an excellent target for prostate cancer imaging and therapy. Finding compounds with a high target-to-nontarget ratio are an important challenge in...